Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.
about
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisCharacterization of metabolically quiescent Leishmania parasites in murine lesions using heavy water labeling.Animal models for the analysis of immune responses to leishmaniasis.Phlebotomine vector ecology in the domestic transmission of American cutaneous leishmaniasis in Chaparral, Colombia.Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis.Congenital transmission of experimental leishmaniasis in a hamster modelNovel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania sppReal-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters.Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment.Leishmaniasis: new insights from an old and neglected disease.Knockdown of Host Antioxidant Defense Genes Enhances the Effect of Glucantime on Intracellular Leishmania braziliensis in Human Macrophages.Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cellsClinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis.Detection of Leishmania (Viannia) DNA in leucocytes from the blood of patients with cutaneous leishmaniasis.
P2860
Q26866450-75F68C28-5B5D-4333-8D70-DED8DF887181Q35122993-2FBD1C4C-5F9B-487E-BB24-3121521DD7FFQ35188674-B9B2F6CB-5312-43E1-85CE-B478174B43B1Q35494417-B4D6A303-8A0C-43F5-8997-F2D9EB57B5E9Q35867155-B27A4D79-3E55-4FE2-A310-EE3013C22F03Q35910551-22F275FD-587B-4C62-B10A-756F9F2885CEQ36118602-7E1CFEDF-034E-4626-883B-12205E6FA2C9Q37026407-18490F6A-E441-4BB6-A85E-7CA6219FDF79Q37089640-0C57F108-C360-4092-B790-FCCC502EEF5EQ37870821-ED9CE50A-B5D9-4552-8BE2-D10B55ACA0B3Q39539764-AAEE9639-BE23-42F1-8C19-042735087C82Q39548200-40728B92-F640-48CA-A98A-A06EED31AC3FQ40124194-E5A9BA52-7B65-45C4-90E2-06F18D16AE24Q40930465-A0FD3F4F-4DD9-4FAF-9AB3-737A6E958582
P2860
Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@ast
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@en
type
label
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@ast
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@en
prefLabel
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@ast
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@en
P2093
P2860
P1476
Viability and burden of Leishm ...... ng human dermal leishmaniasis.
@en
P2093
Adrian Zelazny
Ibeth Romero
Jair Téllez
Maria Cardona
Nancy Gore Saravia
Roger Figueroa
Yazmín Suárez
P2860
P356
10.1371/JOURNAL.PNTD.0000819
P407
P577
2010-09-14T00:00:00Z